Muller & Phipps (India) Limited (MULLER) Share Price
BSE · Healthcare · Pharmaceutical Retailers · ISIN INE003F01015
Key metrics
- Market Cap
- ₹13 Cr
- P/E Ratio
- —
- EPS
- -10.09
- Book Value
- -33.26
- P/B Ratio
- —
- ROE
- 2.28%
- ROCE
- 93.7%
- Debt / Equity
- -0.36
- Net Margin
- -0.84%
- Revenue Growth
- -4.81%
- Profit Growth
- 93.72%
- Dividend Yield
- —
- 52W High
- ₹268.00
- 52W Low
- ₹188.10
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Muller & Phipps (India) Limited
Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; skincare products under the Cavidine and Nixoderm brand name; cosmetics and toiletries, medicated preparations, and food products. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. The Muller & Phipps (India) Limited is a subsidiary of Development Holding Asia Ltd.
- Headquarters
- Mumbai, India
- Promoter Holding
- 79.61%
The full Muller & Phipps (India) Limited analysis
Create a free account to open the complete MULLER deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.